Cargando…
Phenome-based gene discovery provides information about Parkinson’s disease drug targets
BACKGROUND: Parkinson disease (PD) is a severe neurodegenerative disease without curative drugs. The highly complex and heterogeneous disease mechanisms are still unclear. Detecting novel PD associated genes not only contributes in revealing the disease pathogenesis, but also facilitates discovering...
Autores principales: | Chen, Yang, Xu, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009520/ https://www.ncbi.nlm.nih.gov/pubmed/27586503 http://dx.doi.org/10.1186/s12864-016-2820-1 |
Ejemplares similares
-
Phenome-driven disease genetics prediction toward drug discovery
por: Chen, Yang, et al.
Publicado: (2015) -
PhenomeNET: a whole-phenome approach to disease gene discovery
por: Hoehndorf, Robert, et al.
Publicado: (2011) -
Phenomic technologies in drug discovery of neglected diseases
por: Nehrbass, Ulf
Publicado: (2011) -
A phenomics approach for antiviral drug discovery
por: Rietdijk, Jonne, et al.
Publicado: (2021) -
Combining phenome-driven drug-target interaction prediction with patients’ electronic health records-based clinical corroboration toward drug discovery
por: Zhou, Mengshi, et al.
Publicado: (2020)